Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Acute Myeloid Leukemia (AML)”
Approved 3
- MidostaurinNOVARTIS AGAcute Myeloid Leukemia (AML)
- VenetoclaxAbbVie Inc.Acute Myeloid Leukemia (AML)
- ZiftomenibKura Oncology, Inc.Acute Myeloid Leukemia (AML)
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.